<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7290740\results\search\disease\results.xml">
  <result pre=": Article Ethanol Extract of Caesalpinia decapetala Inhibits Influenza Virus" exact="Infection" post="In Vitro and In Vivo https://orcid.org/0000-0003-0639-2431ZhangLi12ChenJungang1KeChang1ZhangHaiwei1ZhangShoujun3TangWei1LiuChunlan1LiuGe12ChenSi12HuAo12SunWenyu12XiaoYu12LiuMinli12https://orcid.org/0000-0002-4479-1145ChenXulin124*[1], zhanglicas000@outlook.comchenjg@wh.iov.cnxiaobinkechang@hotmail.comhwzhang@wh.iov.cntangwei@wh.iov.cnliuchunlan@wh.iov.cnbiohazard_1220@hotmail.comchensi880530@outlook.comhuaocn@foxmail.comwenyu.sun@hotmail.comxiaoyu.cas@foxmail.comminli.liu.work@outlook.com[2], [3], zhangshoujun@wbgcas.cn[4],"/>
  <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza virus" exact="infections" post="can lead to viral pneumonia and acute respiratory distress"/>
  <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza virus infections can lead to" exact="viral pneumonia" post="and acute respiratory distress syndrome in severe cases, causing"/>
  <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza virus infections can lead to viral" exact="pneumonia" post="and acute respiratory distress syndrome in severe cases, causing"/>
  <result pre="Abstract Influenza virus infections can lead to viral pneumonia and" exact="acute" post="respiratory distress syndrome in severe cases, causing significant morbidity"/>
  <result pre="Influenza virus infections can lead to viral pneumonia and acute" exact="respiratory" post="distress syndrome in severe cases, causing significant morbidity and"/>
  <result pre="infections can lead to viral pneumonia and acute respiratory distress" exact="syndrome" post="in severe cases, causing significant morbidity and mortality and"/>
  <result pre="panel of influenza A and B viruses both on human" exact="pulmonary" post="epithelial A549 and human monocytic U937 cells. The animal"/>
  <result pre="of influenza A and B viruses both on human pulmonary" exact="epithelial" post="A549 and human monocytic U937 cells. The animal study"/>
  <result pre="causes substantial morbidity and mortality every year [1]. Vaccination is" exact="limited" post="to the known epidemic strains and takes a long"/>
  <result pre="and the elderly, which cannot shorten the course of the" exact="disease" post="[11]. Since influenza causes a huge burden on society"/>
  <result pre="extracted from Artemisia annua and has been used to treat" exact="malaria" post="[15]. To explore the potential of plant extracts in"/>
  <result pre="the 600 plants in a U937 cell model against influenza" exact="virus infection" post="[16], we found that the ethanol extract of Caesalpinia"/>
  <result pre="600 plants in a U937 cell model against influenza virus" exact="infection" post="[16], we found that the ethanol extract of Caesalpinia"/>
  <result pre="Caesalpinia decapetala (Roth) Alston (EEC) has antiviral activity against influenza" exact="virus infection." post="Caesalpinia decapetala (Roth) Alston (C. decapetala) is a climbing"/>
  <result pre="as a folk medicine to prevent colds, treat bronchitis, and" exact="malaria" post="[20]. However, the extract of C. decapetala has never"/>
  <result pre="of all strains of influenza viruses tested on Madinâ€&quot;Darby Canine" exact="Kidney" post="(MDCK), A549, and U937 cells. The animal experiments showed"/>
  <result pre="and Methods 2.1. Cell Lines, Virus Strains The Madinâ€&quot;Darby Canine" exact="Kidney" post="(MDCK) cells (ATCC CCL-34), human pulmonary epithelial (A549) cells"/>
  <result pre="Strains The Madinâ€&quot;Darby Canine Kidney (MDCK) cells (ATCC CCL-34), human" exact="pulmonary" post="epithelial (A549) cells (ATCC CCL-185), and human monocyte cell"/>
  <result pre="The Madinâ€&quot;Darby Canine Kidney (MDCK) cells (ATCC CCL-34), human pulmonary" exact="epithelial" post="(A549) cells (ATCC CCL-185), and human monocyte cell line"/>
  <result pre="CCL-34), human pulmonary epithelial (A549) cells (ATCC CCL-185), and human" exact="monocyte" post="cell line U973 (ATCC CRL-1593.2) were all preserved in"/>
  <result pre="of different influenza strains were determined using 50% tissue culture" exact="infective" post="dose (TCID50) assay in MDCK cells. 2.2. Preparation of"/>
  <result pre="and infected with the influenza virus in the presence or" exact="absence of" post="the drug. After incubation at 37 Â°C for 48"/>
  <result pre="incubation at 37 Â°C for 48 h, the inhibition of" exact="viral" post="replication was measured by the modified neuraminidase activity (NA)"/>
  <result pre="effective (inhibitory) concentration (EC50). For detection of the production of" exact="infectious" post="virus virions, the supernatants, harvested 48 h post-infection (hpi),"/>
  <result pre="Figure 1A, EEC inhibited the H1N1 influenza virus PR8 strain" exact="infection" post="on A549 cells, with a CC50 and an EC50"/>
  <result pre="1B; the results showed that EEC inhibited the production of" exact="infectious" post="virions potently and concentration-dependently. At concentrations higher than 43"/>
  <result pre="concentration-dependently. At concentrations higher than 43 Î¼g/mL, the production of" exact="infectious" post="influenza virions was below the detection limit (10 TCID50/mL)."/>
  <result pre="influenza epidemics, whereas influenza A viruses can also cause sporadic" exact="infections" post="or spread worldwide in a pandemic when novel strains"/>
  <result pre="on A549 cells at a similar efficiency (Figure 2). During" exact="infection" post="of humans, the influenza virus can infect multiple cell"/>
  <result pre="humans, the influenza virus can infect multiple cell types, including" exact="epithelial" post="cells and monocytes that are important for the pathogenesis"/>
  <result pre="[24]. We next checked the antiviral effect of EEC on" exact="epithelial" post="MDCK cells and monocytic U937 cells against both influenza"/>
  <result pre="the release of influenza viruses. 3.4. EEC Protects Mice from" exact="Lethal" post="Influenza Virus Infection To further study the therapeutic effect"/>
  <result pre="influenza viruses. 3.4. EEC Protects Mice from Lethal Influenza Virus" exact="Infection" post="To further study the therapeutic effect of EEC in"/>
  <result pre="from death caused by the same lethal dose of PR8" exact="virus infection." post="These observations suggest that EEC protects mice from lethal"/>
  <result pre="These observations suggest that EEC protects mice from lethal influenza" exact="virus infection." post="3.5. EEC Reduces Virus Titer and Pathogenic Damage in"/>
  <result pre="and Pathogenic Damage in the Lung Mediated by Influenza Virus" exact="Infection" post="Even though the selective indexes of EEC in the"/>
  <result pre="52 (Table 1), EEC does protect mice from lethal influenza" exact="virus infection." post="To confirm whether EEC inhibits virus replication in vivo,"/>
  <result pre="enhanced inflammatory injuries in the lung [25,26]. To examine the" exact="total" post="cell infiltration and pathological changes in the lungs of"/>
  <result pre="by lethal influenza and treated or untreated with EEC, the" exact="total" post="cell counting in the BALFs and H&amp;amp;E staining of"/>
  <result pre="of mice were conducted. As shown in Figure 4F, the" exact="total" post="number of cells at day 3 and 7 in"/>
  <result pre="antiviral effect of EEC. 4. Discussion/Conclusions Seasonal influenza is an" exact="acute" post="respiratory infection caused by influenza viruses that circulate the"/>
  <result pre="effect of EEC. 4. Discussion/Conclusions Seasonal influenza is an acute" exact="respiratory" post="infection caused by influenza viruses that circulate the world"/>
  <result pre="of EEC. 4. Discussion/Conclusions Seasonal influenza is an acute respiratory" exact="infection" post="caused by influenza viruses that circulate the world [27]."/>
  <result pre="[29]. In patients with influenza pneumonia, multiple cell types, including" exact="epithelial" post="cells, alveolar cells, and monocytes, are infected by the"/>
  <result pre="of EEC against a panel of influenza viruses on the" exact="epithelial" post="A549 cells and monocytic U937 cells. However, the efficacy"/>
  <result pre="2009 (H1N1) pandemic strain, oseltamivir-resistant strain H1N1 (H274Y), and a" exact="bird flu" post="H7N8 were also tested. We did not measure the"/>
  <result pre="Our results demonstrated that EEC protected mice from lethal influenza" exact="infection" post="by increasing the survival rate that is associated with"/>
  <result pre="the in vivo studies, Bing et al. reported that the" exact="total" post="alkaloid extract from Commelina communis showed antiviral activity against"/>
  <result pre="these reported herb medicines, EEC showed similar efficacy to the" exact="total" post="alkaloid extract from Commelina communis. However, it is less"/>
  <result pre="than glycyrrhizin in increasing survival rate, though they both can" exact="lower" post="the virus titer in the lung of mice for"/>
  <result pre="publish the results. References References 1.IulianoA.D.RoguskiK.M.ChangH.H.MuscatelloD.J.PalekarR.TempiaS.MustaquimD.Estimates of global seasonal influenza-associated" exact="respiratory" post="mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 2.KrammerF.The human antibody response to"/>
  <result pre="A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 2.KrammerF.The human antibody response to influenza A" exact="virus infection" post="and vaccinationNat. Rev. Immunol.20191938339710.1038/s41577-019-0143-630837674 3.YamayoshiS.KawaokaY.Current and future influenza vaccinesNat."/>
  <result pre="modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 2.KrammerF.The human antibody response to influenza A virus" exact="infection" post="and vaccinationNat. Rev. Immunol.20191938339710.1038/s41577-019-0143-630837674 3.YamayoshiS.KawaokaY.Current and future influenza vaccinesNat."/>
  <result pre="immunity to influenza virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 26.ShortK.KroezeE.FouchierR.KuikenT.Pathogenesis of influenza-induced" exact="acute" post="respiratory distress syndromeLancet Infect. Dis.201314576910.1016/S1473-3099(13)70286-X24239327 27.KrammerF.SmithG.FouchierR.PeirisJ.S.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis."/>
  <result pre="to influenza virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 26.ShortK.KroezeE.FouchierR.KuikenT.Pathogenesis of influenza-induced acute" exact="respiratory" post="distress syndromeLancet Infect. Dis.201314576910.1016/S1473-3099(13)70286-X24239327 27.KrammerF.SmithG.FouchierR.PeirisJ.S.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068"/>
  <result pre="28.HanA.GiurgeaL.Cervantes-MedinaA.EdwardsK.RosasL.CzajkowskiL.BuasH.A.AthotaR.ReedS.TaubenbergerJ.et al.Sequential Influenza A H1N1 and Influenza A H3N2 Challenge" exact="Infections" post="in Healthy VolunteersOpen Forum Infect. Dis.20196S96910.1093/ofid/ofz360.2427 29.ZhangX.SunH.CunninghamF.LiL.Hanson-DorrK.HopkenM.W.CooleyJ.LongL.-P.BarochJ.A.LiT.et al.Tissue tropisms"/>
  <result pre="29.ZhangX.SunH.CunninghamF.LiL.Hanson-DorrK.HopkenM.W.CooleyJ.LongL.-P.BarochJ.A.LiT.et al.Tissue tropisms opt for transmissible reassortants during avian and" exact="swine influenza" post="A virus co-infection in swinePLoS Pathog.201814e100741710.1371/journal.ppat.100741730507946 30.LiuQ.ZhouY.-H.YangZ.-Q.The cytokine storm"/>
  <result pre="Modulation of Immune ResponsesStud. Nat. Prod. Chem.201238305323 33.BingF.H.LiuJ.LiZ.ZhangG.B.LiaoY.F.LiJ.DongC.Y.Anti-influenza-virus Activity of" exact="Total" post="Alkaloids from Commelina communisL. Arch. Virol.20091541837184010.1007/s00705-009-0503-919774337 34.UtsunomiyaT.KobayashiM.PollardR.B.SuzukiF.Glycyrrhizin, an Active"/>
  <result pre="Licorice Roots, Reduces Morbidity and Mortality of Mice Infected With" exact="Lethal" post="Doses of Influenza VirusAntimicrob Agents Chemother19974155155610.1128/AAC.41.3.5519055991 Figure 1 Caesalpinia"/>
  <result pre="with influenza virus A/Puerto Rico/8/1934 (H1N1) at an multiplicity of" exact="infection" post="(MOI) of 0.25 in the presence or absence of"/>
  <result pre="multiplicity of infection (MOI) of 0.25 in the presence or" exact="absence of" post="serially diluted EEC. Cells were then incubated at 37"/>
  <result pre="NA levels using NA activity assay (A), the production of" exact="infectious" post="virions determined by TCID50 Assay (B), and the expression"/>
  <result pre="diluted EEC was added at the same time during the" exact="virus infection." post="The cells were then incubated at 37 Â°C for"/>
  <result pre="cells. The supernatants were collected at 12 hpi, and the" exact="viral" post="yield was determined by the NA activity assay. (B)"/>
  <result pre="MA, USA). Figure 4 EEC protects mice from lethal influenza" exact="virus infection." post="Six-week-old female BALB/c mice weighing 16â€&quot;18 g were infected"/>
  <result pre="4 EEC protects mice from lethal influenza virus infection. Six-week-old" exact="female" post="BALB/c mice weighing 16â€&quot;18 g were infected with 4"/>
  <result pre="3 and 7 post-infection to monitor virus titers (E), and" exact="total" post="cell counts (F) (mean Â±SEM). The data are representative"/>
  <result pre="of 6 different influenza virus strains in A549, Madinâ€&quot;Darby Canine" exact="Kidney" post="(MDCK), and U937 cells by Caesalpinia decapetala (Roth) Alston"/>
 </snippets>
</snippetsTree>
